ALS drug fails as treatment for early MS
Posted: Tue Oct 08, 2013 2:40 am
Riluzole (Rilutek), a drug used in treatment of patients with amyotrophic lateral sclerosis, did not help prevent brain matter loss in early relapsing/remitting multiple sclerosis, researchers reported here.
After adjustment for key differences in the randomization process, Emmanuelle Waubant, MD, assistant professor of neurology at the University of California San Francisco, said that treatment with riluzole resulted in a decrease in brain volume by 0.26% a year compared with placebo treatment (difference of -0.26, 95% CI -0.057 to 0.014, P=0.22)...... Read More - http://www.ms-uk.org/MSnews
After adjustment for key differences in the randomization process, Emmanuelle Waubant, MD, assistant professor of neurology at the University of California San Francisco, said that treatment with riluzole resulted in a decrease in brain volume by 0.26% a year compared with placebo treatment (difference of -0.26, 95% CI -0.057 to 0.014, P=0.22)...... Read More - http://www.ms-uk.org/MSnews